Maurice Willis

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial

James Chih‐Hsin Yang, D. Ross Camidge, Cheng‐Ta Yang et al. · Journal of Thoracic Oncology · 2020 · 156 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women

Traver J. Wright, E. Lichar Dillon, William J. Durham et al. · Journal of Cachexia Sarcopenia and Muscle · 2018 · 87 citations · Full text

Medicine, Endocrinology, Oncology +17

Isotopic decay of urinary or plasma 3‐methylhistidine as a potential biomarker of pathologic skeletal muscle loss

Melinda Sheffield‐Moore, E. Lichar Dillon, Kathleen M. Randolph et al. · Journal of Cachexia Sarcopenia and Muscle · 2013 · 57 citations · Full text

Life Sciences, Biochemistry, Physiology +11

Cancer cachexia and anabolic interventions: a case report

E. Lichar Dillon, Gurjot Basra, Astrid M. Horstman et al. · Journal of Cachexia Sarcopenia and Muscle · 2012 · 37 citations · Full text

Medicine, Oncology, Pharmacology +15

Microarray, gene sequencing, and reverse transcriptase–polymerase chain reaction analyses of a cryptic PML-RARA translocation

Jason Koshy, You‐Wen Qian, Gayathri Bhagwath et al. · Cancer Genetics · 2012 · 20 citations

Life Sciences, Genetics, Molecular Biology +12